Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Greater Cannabis CoGCAN 30 EBIT per Share is $-0.30 as of Mar. 2026. GuruFocus rates GCAN with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 812 Drug Manufacturers companies, Greater Cannabis Co ranks better than 69.83% on this metric.
Greater Cannabis Co's EBIT per Share for the
three
months ended in Mar. 2026 was $-0.04.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.30.
During the past 3 years, the average EBIT per Share Growth Rate was 21.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 38.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Greater Cannabis Co's EBIT per Share or its related term are showing as below:
GCAN'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -58.3 Med: 43.1 Max: 71.6
Current: 21.1
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Greater Cannabis Co was 71.60% per year. The lowest was -58.30% per year. And the median was 43.10% per year.
GCAN's 3-Year EBIT Growth Rate is ranked better than 69.83% of 812
companies
in the Drug Manufacturers industry
Industry Median: 7.5
vs GCAN: 21.10
Greater Cannabis Co (OTCPK:GCAN) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Greater Cannabis Co EBIT per Share Related Terms
Greater Cannabis Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Greater Cannabis Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Greater Cannabis Co (GCAN) has a EBIT per Share of $-0.30 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Greater Cannabis Co and its competitors. According to the industry distribution chart, Greater Cannabis Co ranks #245 out of 812 companies in the Drug Manufacturers industry, placing it in the top 30.2%.
Is Greater Cannabis Co's EBIT per Share too high?
Greater Cannabis Co's current EBIT per Share is $-0.30. Based on the distribution chart, Greater Cannabis Co ranks #245 out of 812 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Greater Cannabis Co has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Greater Cannabis Co's EBIT per Share compare to STEK and KAYS?
According to the Drug Manufacturers industry distribution chart, Greater Cannabis Co ranks #245 out of 812 companies for EBIT per Share. This puts Greater Cannabis Co in the upper half of its industry. The industry median EBIT per Share is 7.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Greater Cannabis Co and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Greater Cannabis Co's current EBIT per Share is $-0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greater Cannabis Co stock overvalued right now?
Greater Cannabis Co (GCAN) has a current EBIT per Share of $-0.30. The current EBIT per Share is $-0.30. Greater Cannabis Co's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Greater Cannabis Co (GCAN), the current EBIT per Share is $-0.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Greater Cannabis Co Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a pharma-grade therapeutic that reduces disruptive symptoms in patients suffering from neuropsychiatric disorders without the side effects of existing medications. The company is focused on developing new formulations around cannabinoid therapeutics.
30GF Score
Get the complete analysis for GCAN
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GCAN has been successfully added to your 
